IJE Software logoIJEsoft
ServicesPortfolioPricingAboutCase StudyStackNewsBlogPartnerPH NewsMarketsContactGet in touch
← Back to Philippines Business News
Manila Times Business

VIRBAC: A robust adjusted EBIT margin² of 18.8%, driven by solid organic revenue growth of 7.4%

H1 2026 delivered a robust revenue growth of +7.4% and an adjusted EBIT margin2 of 18.8% at CERS:Revenue growth is coming from both segments : companion animal +10.0% and farm animal +6.7% with a strong contribution from our Supercharge platforms (excl. Thyronorm) which increased by around +12% at CERS Solid volume/mix effect of ~+5.4%, completed by price increase of ~+2%Operating margin increased by 0.5ppt compared to H1 2025 driven by a favorable mix effect on the gross margin partially offset

Context & Analysis

For Philippine readers, the most useful read on this report is not that a foreign animal-health company posted strong numbers, but what it says about demand for veterinary inputs across two markets that touch local businesses and households. Pet care has become a visible part of urban consumption, with owners increasingly spending on vaccines, diagnostics, preventive medicines, and specialized services rather than waiting until animals are sick. Livestock health is less visible but commercially critical, because disease control affects productivity, feed efficiency, and food supply stability for poultry, swine, and other sectors that employ many workers.

The report suggests that global buyers of animal-health products are still prioritizing quality inputs even when operating margins are squeezed by inflation, logistics costs, and currency swings. For Philippine importers, distributors, pet clinics, and livestock firms, that can translate into two competing effects. On one hand, an established supplier with strong demand may have more capacity to support global markets, including emerging regions where animal-health infrastructure is expanding. On the other hand, pricing power in a tight supply chain can push up landed costs for vaccines and medicines, especially if the peso weakens or shipping costs rise.

This matters because veterinary spending is often treated as discretionary by pet owners but necessary by commercial farmers. In a Philippine economy still sensitive to inflation and consumer cash flow, even modest increases in imported animal-health products can ripple through small clinics, independent vets, backyard poultry operations, and integrated farms that depend on reliable disease prevention. Regulatory filings, import compliance, and local distribution capacity will also shape how quickly these global product trends reach Filipino customers.

What to watch next is whether the supplier’s growth comes from new products or simply pricing, and how Philippine buyers respond to any cost increases. For businesses, the key variables are peso movements, input costs, livestock cycles, and the pace of pet-ownership spending. For investors, the broader signal is that animal health remains a defensive niche: demand is less cyclical than consumer electronics or autos, but still exposed to agricultural cycles, regulation, and import economics.

Analysis by IJE Software — original commentary on the story above.

This is an excerpt. Read the full article at the original source:

Source: manilatimes.net

More from Manila Times Business

HEADLINES: Prosecutors to probe VP's Davao ventures | September 18, 2026

4h ago

Today's Front Page | September 18, 2026

4h ago

USO Announces Celebrity Chef Carla Hall as Global Ambassador

4h ago

Soitec launches an offering of bonds settled in cash and/or convertible into new shares and/or exchangeable for existing shares ("ORNANES”) due September 2033 for a nominal amount of €500 million

4h ago

Your Daily Briefing

AI business companion — delivered every morning

Markets, PH news, financial insights, and devotionals — curated by AI and sent at 7 AM PHT. Pick your topics below.

Devotionals
Blog Topics
HR & Workforce
Real Estate & Property
News & Markets

1 topic selected